CRP and hepatocellular carcinoma: Increased levels of baseline AFP (P= .002), NLR (P= .043), AAR (P= .006), ALBI score (P= .027), SII (P= .012), and lower CALLY index (P= .005) and N/CRP ratio (P= .034) were prognostic impacts for non-complete treatment response for HCC.